These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 18584889)
1. High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery. Ge F; Xiong S; Lin FS; Zhang ZP; Zhang XE Antiviral Res; 2008 Nov; 80(2):107-13. PubMed ID: 18584889 [TBL] [Abstract][Full Text] [Related]
2. Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies. Nguyen HT; Falzarano D; Gerdts V; Liu Q J Virol; 2021 Aug; 95(18):e0068721. PubMed ID: 34191580 [TBL] [Abstract][Full Text] [Related]
3. Helicases as antiviral drug targets. Huang JD; Zheng BJ; Sun HZ Hong Kong Med J; 2008 Aug; 14 Suppl 4():36-8. PubMed ID: 18708673 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 replicon for high-throughput antiviral screening. Zhang QY; Deng CL; Liu J; Li JQ; Zhang HQ; Li N; Zhang YN; Li XD; Zhang B; Xu Y; Ye HQ J Gen Virol; 2021 May; 102(5):. PubMed ID: 33956592 [TBL] [Abstract][Full Text] [Related]
5. Development of a homogeneous screening assay for automated detection of antiviral agents active against severe acute respiratory syndrome-associated coronavirus. Ivens T; Van den Eynde C; Van Acker K; Nijs E; Dams G; Bettens E; Ohagen A; Pauwels R; Hertogs K J Virol Methods; 2005 Oct; 129(1):56-63. PubMed ID: 15961169 [TBL] [Abstract][Full Text] [Related]
6. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. Chen L; Gui C; Luo X; Yang Q; Günther S; Scandella E; Drosten C; Bai D; He X; Ludewig B; Chen J; Luo H; Yang Y; Yang Y; Zou J; Thiel V; Chen K; Shen J; Shen X; Jiang H J Virol; 2005 Jun; 79(11):7095-103. PubMed ID: 15890949 [TBL] [Abstract][Full Text] [Related]
7. Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA. Hertzig T; Scandella E; Schelle B; Ziebuhr J; Siddell SG; Ludewig B; Thiel V J Gen Virol; 2004 Jun; 85(Pt 6):1717-1725. PubMed ID: 15166457 [TBL] [Abstract][Full Text] [Related]
8. Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase. Adedeji AO; Singh K; Calcaterra NE; DeDiego ML; Enjuanes L; Weiss S; Sarafianos SG Antimicrob Agents Chemother; 2012 Sep; 56(9):4718-28. PubMed ID: 22733076 [TBL] [Abstract][Full Text] [Related]
9. Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing. He X; Quan S; Xu M; Rodriguez S; Goh SL; Wei J; Fridman A; Koeplinger KA; Carroll SS; Grobler JA; Espeseth AS; Olsen DB; Hazuda DJ; Wang D Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33766889 [TBL] [Abstract][Full Text] [Related]
10. Construction of a non-infectious SARS coronavirus replicon for application in drug screening and analysis of viral protein function. Wang JM; Wang LF; Shi ZL Biochem Biophys Res Commun; 2008 Sep; 374(1):138-42. PubMed ID: 18619943 [TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomics analysis reveals BAG3 as a potential target to suppress severe acute respiratory syndrome coronavirus replication. Zhang L; Zhang ZP; Zhang XE; Lin FS; Ge F J Virol; 2010 Jun; 84(12):6050-9. PubMed ID: 20392858 [TBL] [Abstract][Full Text] [Related]
12. Derivation of a novel SARS-coronavirus replicon cell line and its application for anti-SARS drug screening. Ge F; Luo Y; Liew PX; Hung E Virology; 2007 Mar; 360(1):150-8. PubMed ID: 17098272 [TBL] [Abstract][Full Text] [Related]
13. Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics. Kao RY; Tsui WH; Lee TS; Tanner JA; Watt RM; Huang JD; Hu L; Chen G; Chen Z; Zhang L; He T; Chan KH; Tse H; To AP; Ng LW; Wong BC; Tsoi HW; Yang D; Ho DD; Yuen KY Chem Biol; 2004 Sep; 11(9):1293-9. PubMed ID: 15380189 [TBL] [Abstract][Full Text] [Related]
14. Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay. Elshabrawy HA; Fan J; Haddad CS; Ratia K; Broder CC; Caffrey M; Prabhakar BS J Virol; 2014 Apr; 88(8):4353-65. PubMed ID: 24501399 [TBL] [Abstract][Full Text] [Related]
15. Discovery of small molecule inhibitors of West Nile virus using a high-throughput sub-genomic replicon screen. Gu B; Ouzunov S; Wang L; Mason P; Bourne N; Cuconati A; Block TM Antiviral Res; 2006 Jun; 70(2):39-50. PubMed ID: 16724398 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin. Kumaki Y; Wandersee MK; Smith AJ; Zhou Y; Simmons G; Nelson NM; Bailey KW; Vest ZG; Li JK; Chan PK; Smee DF; Barnard DL Antiviral Res; 2011 Apr; 90(1):22-32. PubMed ID: 21338626 [TBL] [Abstract][Full Text] [Related]
17. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase. Bertolin AP; Weissmann F; Zeng J; Posse V; Milligan JC; Canal B; Ulferts R; Wu M; Drury LS; Howell M; Beale R; Diffley JFX Biochem J; 2021 Jul; 478(13):2425-2443. PubMed ID: 34198323 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus. Saijo M; Morikawa S; Fukushi S; Mizutani T; Hasegawa H; Nagata N; Iwata N; Kurane I Antiviral Res; 2005 Jun; 66(2-3):159-63. PubMed ID: 15911031 [TBL] [Abstract][Full Text] [Related]
19. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. de Wilde AH; Jochmans D; Posthuma CC; Zevenhoven-Dobbe JC; van Nieuwkoop S; Bestebroer TM; van den Hoogen BG; Neyts J; Snijder EJ Antimicrob Agents Chemother; 2014 Aug; 58(8):4875-84. PubMed ID: 24841269 [TBL] [Abstract][Full Text] [Related]
20. Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen. Liu S; Chou CK; Wu WW; Luan B; Wang TT J Virol; 2022 Mar; 96(6):e0221621. PubMed ID: 35080424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]